p16ink4a expression decreases during imiquimod treatment of anal intraepithelial neoplasia in human immunodeficiency virus-infected men and correlates with the decline of lesional high-risk human papillomavirus DNA load

British Journal of Dermatology

Volumn 157, Issue 3, 2007, Pages 523-530

  Kreuter, A ^a   Wieland, U ^b   Gambichler, T ^a   Altmeyer, P ^a   Pfister, H ^b   Tenner Racz, K ^c   Racz, P ^c   Potthoff, A ^a   Brockmeyer, N H ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

^b UNIVERSITY OF COLOGNE   (Germany)

^c BERNHARD NOCHT INSTITUTE FOR TROPICAL MEDICINE   (Germany)

Author keywords

Anal intraepithelial neoplasia; Human immunodeficiency virus infection; Human papillomavirus DNA load; Human papillomavirus infection; p16ink4a; Proliferative biomarkers

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 1; IMIQUIMOD; KI 67 ANTIGEN; MINICHROMOSOME MAINTENANCE PROTEIN; PROTEIN P16INK4A; VIRUS DNA; AMINOQUINOLINE DERIVATIVE; ANTINEOPLASTIC AGENT; CYCLIN DEPENDENT KINASE INHIBITOR 2A; TUMOR MARKER;

ANUS INTRAEPITHELIAL TUMOR; ANUS TUMOR; ARTICLE; CLINICAL ARTICLE; HISTOPATHOLOGY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPE 31; HUMAN PAPILLOMAVIRUS TYPE 33; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; VIRUS LOAD; WART VIRUS; ADULT; AIDS RELATED COMPLEX; CARCINOMA IN SITU; GENETICS; HOMOSEXUALITY; INTRADERMAL DRUG ADMINISTRATION; MALE; METABOLISM; PAPILLOMA VIRUS; PILOT STUDY; PRECANCER; VIROLOGY; VIRUS INFECTION;

ADMINISTRATION, CUTANEOUS; ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; AMINOQUINOLINES; ANTINEOPLASTIC AGENTS; ANUS NEOPLASMS; CARCINOMA IN SITU; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DNA, VIRAL; HOMOSEXUALITY, MALE; HUMANS; KI-67 ANTIGEN; MALE; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PILOT PROJECTS; PRECANCEROUS CONDITIONS; TUMOR MARKERS, BIOLOGICAL; VIRAL LOAD;

EID: 34547925605     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2007.08004.x     Document Type: Article

References (30)

1. Fenger C, Nielsen VT. Dysplastic changes in the anal canal epithelium in minor surgical specimens. Acta Pathol Microbiol Immunol Scand 1981 89 : 463 5.
2. Palefsky JM. Human papillomavirus infection and anogenital neoplasia in human immunodeficiency virus-positive men and women. J Natl Cancer Inst Monogr 1998 23 : 15 20.
3. Palefsky JM, Holly EA, Efirdc JT et al. Anal intraepithelial neoplasia in the highly active antiretroviral therapy era among HIV-positive men who have sex with men. AIDS 2005 19 : 1407 14.
4. Kreuter A, Brockmeyer N, Hochdorfer B et al. Clinical spectrum and virologic characteristics of anal intraepithelial neoplasia in HIV infection. J Am Acad Dermatol 2005 52 : 603 8.
5. Frisch M, Biggar RJ, Goedert JJ. Human papillomavirus-associated cancers in patients with human immunodeficiency virus infection and acquired immunodeficiency syndrome. J Natl Cancer Inst 2000 92 : 1500 10.
6. Chiao EY, Giordano TP, Palefsky JM et al. Screening HIV-infected individuals for anal cancer precursor lesions: a systematic review. Clin Infect Dis 2006 43 : 223 33.
7. Burns CA, Brown MD. Imiquimod for the treatment of skin cancer. Dermatol Clin 2005 23 : 151 64.
8. Kreuter A, Hochdorfer B, Stücker M et al. Treatment of anal intraepithelial neoplasia in patients with acquired HIV with imiquimod 5% cream. J Am Acad Dermatol 2004 50 : 980 1.
9. Wieland U, Brockmeyer NH, Weissenborn SJ et al. Imiquimod treatment of anal intraepithelial neoplasia in HIV-positive men. Arch Dermatol 2006 142 : 1438 44.
10. Padilla Paz LA. Emerging technology in cervical cancer screening: status of molecular markers. Clin Obstet Gynecol 2005 48 : 218 25.
11. Jacobs MV, Snijders PJF, van den Brule AJC et al. A general primer GP5+/GP6+-mediated PCR-enzyme immunoassay method for rapid detection of 14 high-risk and 6 low-risk human papillomavirus genotypes in cervical scrapings. J Clin Microbiol 1997 35 : 791 5.
12. van den Brule AJ, Pol R, Fransen-Daalmeijer N et al. GP5+/6+ PCR followed by reverse line blot analysis enables rapid and high-throughput identification of human papillomavirus genotypes. J Clin Microbiol 2002 40 : 779 87.
13. Weissenborn SJ, Funke AM, Hellmich M et al. Oncogenic human papillomavirus DNA loads in human immunodeficiency virus-positive women with high-grade cervical lesions are strongly elevated. J Clin Microbiol 2003 41 : 2763 7.
14. Palefsky JM, Holly EA, Hogeboom CJ et al. Virologic, immunologic, and clinical parameters in the incidence and progression of anal squamous intraepithelial lesions in HIV-positive and HIV-negative homosexual men. J Acquir Immune Defic Syndr Hum Retrovirol 1998 17 : 314 19.
15. Panther LS, Wagner K, Proper J et al. High resolution anoscopy findings in men who have sex with men: inaccuracy of anal cytology as a predictor of histologic high grade anal intraepithelial neoplasia and the impact of HIV serostatus. Clin Infect Dis 2004 38 : 1490 2.
16. Lytwyn A, Salit IE, Raboud J et al. Interobserver agreement in the interpretation of anal intraepithelial neoplasia. Cancer 2005 103 : 1447 56.
17. Chang GJ, Berry JM, Jay N et al. Surgical treatment of high-grade anal squamous intraepithelial lesions: a prospective study. Dis Colon Rectum 2002 45 : 453 8.
18. von Knebel Doeberitz M. New markers for cervical dysplasia to visualise the genomic chaos created by aberrant oncogenic papillomavirus infections. Eur J Cancer 2002 38 : 2229 42.
19. Ortega S, Malumbres M, Barbacid M. Cyclin D-dependent kinases, INK4 inhibitors, and cancer. Biochim Biophys Acta 2002 1602 : 73 87.
20. Sano T, Oyama T, Kashiwathara K et al. Expression status of p16 protein is associated with human papillomavirus oncogenic potential in cervical and genital lesions. Am J Pathol 1998 153 : 1741 8.
21. Klaes R, Friedrich T, Spitkovsky D et al. Overexpression of p16(INK4A) as a specific marker for dysplastic and neoplastic epithelial cells of the cervix uteri. Int J Cancer 2001 92 : 276 84.
22. Walts AE, Lachago J, Bose S. P16 and Ki67 immunostaining is a useful adjunct in the assessment of biopsies for HPV-associated anal intraepithelial neoplasia. Am J Surg Pathol 2006 30 : 795 801.
23. Indinnimeo M, Cicchini C, Stazi A et al. Immunohistochemical assessment of Ki67 as prognostic cellular proliferation marker in anal canal carcinoma. J Exp Clin Cancer Res 2000 19 : 471 5.
24. Williams GH, Romanowski P, Morris LS et al. Improved cervical smear assessment using antibodies against proteins that regulate DNA replication. Proc Natl Acad Sci USA 1998 95 : 14932 7.
25. Maga G, Hubscher U. Proliferating cell nuclear antigen (PCNA): a dancer with many partners. J Cell Sci 2003 116 : 3051 60.
26. van de Putte G, Holm R, Lie AK et al. Expression of p27, p21, and p16 protein in early squamous cervical cancer and its relation to prognosis. Gynecol Oncol 2003 89 : 140 7.
27. Agoff SN, Lin P, Morihara J et al. P16 (INK4a) expression correlates with degree of cervical neoplasia: a comparison with Ki-67 expression and detection of high-risk HPV types. Mod Pathol 2003 16 : 665 73.
28. Freeman A, Morris LS, Mills AD et al. Minichromosome maintenance proteins as biological markers of dysplasia and malignancy. Clin Cancer Res 1999 5 : 2121 32.
29. Wang JL, Zheng BY, Li XD et al. Predictive significance of the alterations of p16INK4A, p14ARF, p53, and proliferating cell nuclear antigen expression in the progression of cervical cancer. Clin Cancer Res 2004 10 : 2407 14.
30. Gartel AL, Tyner AL. The role of the cyclin-dependent kinase inhibitor p21 in apoptosis. Mol Cancer Ther 2002 1 : 639 49.